PLASMA O-METHYLDOPA IN LEVODOPA-INDUCED DYSKINESIAS A Bioclinical Investigation
Authors:
- 29 January 2009
- journal article
- research article
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 56 (6) , 508-524
Abstract
The peripheral metabolism of Dopa has been studied in correlation with the clinical occurrence of Leyodopa-induced dyskinesias in Parkinson patients. Within the group of patients treated with a peripheral decarboxylase inhibitor (PDI), the combination of all the plasma levels of O-Methyldopa from patients with dyskinesias shows significantly higher values than those from patients without dyskinesias. For Dopa itself, no significant differnece can be detected. Such high O-Methyldopa levels seem to be due to a progressive accumulation of this compound and not to a higher degree of formation. In contrast, no significantly different Dopa or O-Methyldopa levels are found within the group of patients treated with L-Dopa alone. These results are discussed in relation to some of the suspected mechanisms involved in Levodopa-induced dyskinesias.Keywords
This publication has 37 references indexed in Scilit:
- On‐off responseNeurology, 1975
- Levodopa-Induced DyskinesiasArchives of Neurology, 1973
- Parkinsonism treated with 3‐0‐methyldopaClinical Pharmacology & Therapeutics, 1973
- Drug Therapy of ParkinsonismNew England Journal of Medicine, 1972
- Effects of levodopa on nondopaminergic brain neuronsNeurology, 1972
- Inhibition of catechol-O-methyl transferase by l-dopa and decarboxylase inhibitorsJournal of Pharmacy and Pharmacology, 1972
- Postsynaptic Supersensitivity after 6‐Hydroxy‐dopamine Induced Degeneration of the Nigro‐striatal Dopamine SystemActa Physiologica Scandinavica, 1971
- Inhibition of Serotonin Synthesis by Dopa and Other CatecholsNature New Biology, 1971
- The choreoathetoid movement disorder induced by levodopaClinical Pharmacology & Therapeutics, 1971
- Plasma DOPA response to levodopa administration in man: Effects of a peripheral decarboxylase inhibitorClinical Pharmacology & Therapeutics, 1971